18
Views
8
CrossRef citations to date
0
Altmetric
CASE REPORT

A case of life-threatening refractory polychondritis successfully treated with combined intensive immunosuppressive therapy with methotrexate

, , , , , , & show all
Pages 144-147 | Received 14 Sep 2006, Accepted 02 Nov 2006, Published online: 02 Jan 2014

References

  • Foidart JM, Abe S, Martin GR, Zizic TM, Barnett EV, Lawley TJ, et al. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 1978;299:1203–7.
  • Lang B, Rothenfusser A, Lanchbury JS, Rauh G, Breedveld FC, Urlacher A, et al. Susceptibility to relapsing polychondritis is as-sociated with HLA-DR4. Arthritis Rheum 1993;36:660–4.
  • Michet CJ Jr, McKenna CH, Luthra HS, O'Fallon WM. Relapsing polychondritis: Survival and predictive role of early disease mani-festation. Ann Intern Med 1986;104:74–8.
  • McAdam LP, O'Hanlan MA, Bluestone R, Pearson CM. Relaps-ing polychondritis: prospective study of 23 patients and review of the literature. Medicine 1976;55:193–215.
  • Letko E, Zafirakis P, Baltatzis S, Voudouri A, Livir-Rallatos C, Foster CS. Relapsing Polychondritis: a clinical review. Semin Ar-thritis Rheum 2002;31:384–95.
  • Michet CJ. Vasculitis and relapsing polychondritis. Rheum Dis Chin North Am 1990;16:441–4.
  • Trentham DE, Le CH. Relapsing polychondritis. Ann Intern Med 1998;129:114–22.
  • Geffriaud-Fticouard C, Noel LH, Chauveau D, Houhou S, Grun-feld JP, Lesavre P. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol 1993;39: 125–36.
  • Lipnick RN, Fink CW. Acute airway obstruction in relapsing poly-chondritis: treatment with pulse methyprednisolone. J Ftheumatol 1991;18:98–9.
  • Ruhlen JL, Huston KA, Wood WG. Relapsing polychondritis with glomerulonephritis: improvement with prednisone and cyclophos-phamide. JAMA 1981;245:847–8.
  • Svenson KL, Holmdahl R, Klareskog L, Wibell L, Sjoberg 0, Klintmalm GB, et al. Cyclosporin A treatment in a case of relaps-ing polychondritis. Scand J Ftheumatol 1984;13:329–33.
  • Park J, Gowin KM, Schumacher HR Jr. Steroid sparing effect of methotrexate in relapsing polychondritis. J Ftheumatol 1996;23: 937–8.
  • Sarodia BD, Dasgupta A, Mehta AC. Management of airway manifestation of relapsing polychondritis: case reports and review of literature. Chest 1999;116:1669–75.
  • Yu EN, Jurkunas U, Rubin PA, Baltatzis S, Foster CS. Obliterative microangiopathy presenting as chronic conjunctivitis in a patient with relapsing polychondritis. Cornea 2006;25:621–2.
  • Tesche S, Wenzel S, Sagowski C. Relapsing polychondritis-a case report and review of the literature. Laryngorhinootologie 2005; 84:352–6.
  • Ogawa H, Nishi E, Kameda H, Amano K, Takeuchi T. Manifesta-tion mimicking relapsing polychondritis in a patient with micro-scopic polyangiitis (in Japanese). Nihon Ftinsho Meneki Gakkai Kaishi 2005;28:104–8.
  • Chang SJ, Lu CC, Chung YM, Lee SS, Chou CT, Huang DF. La-ryngotracheal involvement as the initial manifestation of relapsing polychondritis. J Chin Med Assoc 2005;68:279–82.
  • Hellmich B, Hering S, Duchna HW, Shultze-Werninghaus G, Freitag L, Schatz H, et al. Airway manifestation of relapsing poly-chondritis: treatment with cyclophosphamide and placement of bronchial stents. Z Ftheumatol 2003;62:73–9.
  • Hoang-Xaun T, Foster CS, Rice BA. Sderitis in relapsing polychondritis. Response to therapy. Ophthalmology 1990;97: 892–8.
  • Adler D, Broker HJ, Simmling-Annefeld M. Relapsing polychon-dritis. A case report with special reference to otolaryngological manifestations. Laryngol Fthinol Otol 1981;60:187–91.
  • Vounotrypidis P, Sakellariou GT, Zisopoulos D, Berberidis C. Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra). Ftheumatology (Oxf) 2006;45:491–2.
  • Carter JD. Treatment of relapsing polychondritis with a TNF an-tagonist. J Ftheumatol 2005;32:1413.
  • Cazabon S, Over K, Butcher J. The successful use of infliximab in resistant relapsing polychondritis and associated sderitis. Eye 2005;19:222–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.